These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 26695501)

  • 1. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.
    Lima da Silva G; Nunes-Ferreira A; Cortez-Dias N; de Sousa J; J Pinto F; Caldeira D
    J Interv Card Electrophysiol; 2020 Dec; 59(3):603-616. PubMed ID: 32948937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease.
    Martinez BK; Baker WL; Konopka A; Giannelli D; Coleman CI; Kluger J; Cronin EM
    Heart Rhythm; 2020 Jan; 17(1):e206-e219. PubMed ID: 31082362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
    Atti V; Vuddanda V; Turagam MK; Vemula P; Shah Z; Nagam H; Yandrapalli S; Jazayeri MA; Koerber S; Gonzalez JV; Natale A; Di Biase L; Lakkireddy DR
    J Interv Card Electrophysiol; 2018 Nov; 53(2):207-215. PubMed ID: 29680972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials.
    Maskoun W; Saad M; Abualsuod A; Nairooz R; Miller JM
    Int J Cardiol; 2018 Sep; 267():107-113. PubMed ID: 29655948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.
    Liu G; Xu X; Yi Q; Lv T
    J Interv Card Electrophysiol; 2021 Sep; 61(3):435-443. PubMed ID: 33723693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
    Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
    Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catheter ablation of ventricular tachycardia : What have we achieved?].
    Konrad T; Hoffmann BA; Rostock T
    Herz; 2017 Apr; 42(2):132-137. PubMed ID: 28229198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Kheiri B; Barbarawi M; Zayed Y; Hicks M; Osman M; Rashdan L; Kyi HH; Bachuwa G; Hassan M; Stecker EC; Nazer B; Bhatt DL
    Circ Arrhythm Electrophysiol; 2019 Nov; 12(11):e007600. PubMed ID: 31698933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort.
    Yousuf OK; Zusterzeel R; Sanders W; Caños D; Dekmezian C; Silverman H; Calkins H; Berger R; Tandri H; Nazarian S; Strauss DG
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1189-1199. PubMed ID: 30236393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized controlled trials.
    Prasitlumkum N; Navaravong L; Desai A; Desai D; Cheungpasitporn W; Rattanawong P; Bunch TJ; Jongnarangsin K; Chokesuwattanaskul R
    Heart Rhythm; 2022 Dec; 19(12):2054-2061. PubMed ID: 35820619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of recent studies in catheter ablation of ventricular tachycardias: in whom to abandon the ICD?
    Arya A; Piorkowski C; Kircher S; Sommer P; Bollmann A; Gaspar T; Hindricks G
    Herz; 2009 Nov; 34(7):539-44. PubMed ID: 20091253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.
    Wissner E; Stevenson WG; Kuck KH
    Eur Heart J; 2012 Jun; 33(12):1440-50. PubMed ID: 22411192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.